WuXi Biologics (Cayman) Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WXXWY research report →
Price Chart
About the company
WuXi Biologics (Cayman) Inc. delivers integrated solutions covering the entire lifecycle of biological drug development, from initial discovery to full-scale manufacturing. These services are provided to clients worldwide, with a significant presence in China, North America, and Europe.
- CEO
- Zhisheng Chen
- IPO
- 2017
- Employees
- 13,252
- HQ
- Wuxi, JS, CN
Get TickerSpark's AI analysis on WXXWY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $28.94B
- P/E
- 37.98
- Fwd P/E
- 4.77
- PEG
- 1.92
- P/S
- 8.06
- P/B
- 3.92
- EV/EBITDA
- 19.45
- Div Yield
- 0.00%
- Gross Margin
- 47.47%
- Op Margin
- 32.36%
- Net Margin
- 21.20%
- ROE
- 10.51%
- ROIC
- 10.60%
Latest fiscal year · YoY change
- Revenue
- $21.20B+13.5%
- Gross Profit
- $9.75B+27.4%
- Op Income
- $6.47B
- Net Income
- $4.77B+42.3%
- EPS
- $2.38+52.6%
- OCF Growth
- +22.3%
- FCF Growth
- +117.1%
- 52W High
- $14.80
- 52W Low
- $5.50
- 50D MA
- $12.53
- 200D MA
- $9.92
- Beta
- 0.60
- RSI (14)
- 55
- Avg Volume
- 66.37K
No earnings-call transcripts are available for WXXWY yet.
- Free Float
- 90.9%
- Shares Outstanding
- 2.05B
- Float Shares
- 1.87B
Held by 2 ETFs
Biggest fund positions in WXXWY by dollar value.
Our WXXWY coverage
Recent articles, reports, and earnings notes.
No research on WXXWY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WXXWY report →WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Hits New 1-Year High – Still a Buy?
defenseworld.net · Oct 6
WuXi Biologics (Cayman) Inc. (WXXWY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 27
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Down 81.8% in July
defenseworld.net · Aug 12
WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations
prnewswire.com · Jun 24
WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market
prnewswire.com · Jun 18
WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
prnewswire.com · Jun 8
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
prnewswire.com · Jun 4
WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year
prnewswire.com · Jun 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.